Outlook Therapeutics, Inc. (OTLK) Operating cash flow 2016–2025
Outlook Therapeutics, Inc. (OTLK) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$51.8MFY2025 · since FY2016: -$45.5M → -$51.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$51.8M | +24.7% |
| FY2024 | -$68.8M | -60.1% |
| FY2023 | -$43.0M | +24.2% |
| FY2022 | -$56.7M | -4.5% |
| FY2021 | -$54.3M | -70.7% |
| FY2020 | -$31.8M | +1.5% |
| FY2019 | -$32.3M | +2.3% |
| FY2018 | -$33.0M | -113.1% |
| FY2017 | -$15.5M | +65.9% |
| FY2016 | -$45.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice